Banco Santander’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $49M | Sell |
807,784
-16,278
| -2% | -$949K | 0.4% | 37 |
|
|
2025
Q4 | $44.4M | Buy |
824,062
+320,137
| +64% | +$15.4M | 0.33% | 47 |
|
|
2025
Q3 | $22.7M | Buy |
503,925
+262,372
| +109% | +$12.3M | 0.2% | 87 |
|
|
2025
Q2 | $11.2M | Buy |
241,553
+26,341
| +12% | +$1.29M | 0.11% | 131 |
|
|
2025
Q1 | $13.1M | Buy |
215,212
+34,496
| +19% | +$2.01M | 0.14% | 106 |
|
|
2024
Q4 | $10.2M | Sell |
180,716
-295,182
| -62% | -$16.5M | 0.12% | 121 |
|
|
2024
Q3 | $24.6M | Buy |
475,898
+22,300
| +5% | +$1.05M | 0.29% | 55 |
|
|
2024
Q2 | $18.8M | Buy |
453,598
+36,151
| +9% | +$1.62M | 0.23% | 70 |
|
|
2024
Q1 | $22.6M | Buy |
417,447
+35,361
| +9% | +$1.8M | 0.27% | 55 |
|
|
2023
Q4 | $19.6M | Buy |
382,086
+45,705
| +14% | +$2.4M | 0.23% | 62 |
|
|
2023
Q3 | $19.5M | Sell |
336,381
-5,861
| -2% | -$359K | 0.28% | 54 |
|
|
2023
Q2 | $21.9M | Buy |
342,242
+290,577
| +562% | +$19.5M | 0.29% | 50 |
|
|
2023
Q1 | $3.58M | Buy |
51,665
+48,826
| +1,720% | +$3.44M | 0.05% | 149 |
|
|
2022
Q4 | $204K | Buy |
+2,839
| New | +$214K | ﹤0.01% | 349 |
|
|
2021
Q4 | – | Sell |
-3,441
| Closed | -$204K | – | 421 |
|
|
2021
Q3 | $204K | Hold |
3,441
| – | – | ﹤0.01% | 400 |
|
|
2021
Q2 | $230K | Hold |
3,441
| – | – | ﹤0.01% | 381 |
|
|
2021
Q1 | $217K | Sell |
3,441
-3,959
| -54% | -$246K | ﹤0.01% | 382 |
|
|
2020
Q4 | $459K | Buy |
7,400
+2,397
| +48% | +$147K | ﹤0.01% | 314 |
|
|
2020
Q3 | $302K | Hold |
5,003
| – | – | ﹤0.01% | 319 |
|
|
2020
Q2 | $294K | Sell |
5,003
-506
| -9% | -$30.3K | ﹤0.01% | 307 |
|
|
2020
Q1 | $307K | Sell |
5,509
-8,451
| -61% | -$517K | ﹤0.01% | 341 |
|
|
2019
Q4 | $896K | Sell |
13,960
-382
| -3% | -$21.9K | 0.01% | 271 |
|
|
2019
Q3 | $727K | Buy |
14,342
+4,442
| +45% | +$209K | 0.01% | 281 |
|
|
2019
Q2 | $449K | Sell |
9,900
-10,139
| -51% | -$472K | ﹤0.01% | 319 |
|
|
2019
Q1 | $956K | Sell |
20,039
-3,456
| -15% | -$172K | 0.01% | 234 |
|
|
2018
Q4 | $1.22M | Buy |
23,495
+3,832
| +19% | +$206K | 0.02% | 224 |
|
|
2018
Q3 | $1.22M | Sell |
19,663
-58,682
| -75% | -$3.48M | 0.01% | 234 |
|
|
2018
Q2 | $4.34M | Buy |
78,345
+1,458
| +2% | +$78.7K | 0.05% | 160 |
|
|
2018
Q1 | $4.86M | Buy |
+76,887
| New | +$4.95M | 0.06% | 159 |
|
Other funds holding BMY
VCM
VPM
Banco Santander's BMY Position: Q1 2026 in Review
Banco Santander reduced its Bristol-Myers Squibb (BMY) stake by 2% in Q1 2026, selling an estimated $949K and leaving 807,784 shares worth $49M. The position accounts for 0.4% of the portfolio, ranked #37.
Banco Santander first reported a position in BMY in Q1 2018 and has held it in 29 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Banco Santander held 807,784 shares of Bristol-Myers Squibb worth $49M as of Q1 2026.
- Banco Santander sold 16,278 Bristol-Myers Squibb shares in Q1 2026, an estimated $949K.
- Bristol-Myers Squibb made up 0.4% of Banco Santander's portfolio in Q1 2026, its #37 holding.
- Banco Santander first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 29 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Banco Santander's 13F filing for Q1 2026, filed 8 May 2026.